Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray-based gene expression profiling of hematologic malignancies: basic concepts and clinical applications.

Ofer Margalit1, Raz Somech, Ninette Amariglio

  • 1Pediatric Hematology-Oncology, Safra Children's Hospital, The Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.

Blood Reviews
|March 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BRAF mutations and targeted therapy in unclassified pericytic tumors: insights from genetic analysis and clinical response.

BMC cancer·2025
Same author

Genotoxicity Associated with Retroviral CAR Transduction of ATM-Deficient T Cells.

Blood cancer discovery·2024
Same author

Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.

Journal of the National Cancer Institute·2023
Same author

Clinical impact of exome sequencing in the setting of a general pediatric ward for hospitalized children with suspected genetic disorders.

Frontiers in genetics·2023
Same author

Cutaneous and Developmental Effects of <i>CARD14</i> Overexpression in Zebrafish.

Biomedicines·2022
Same author

SurviveAI: Long Term Survival Prediction of Cancer Patients Based on Somatic RNA-Seq Expression.

Cancer informatics·2022
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Microarray technology and bioinformatics analysis revolutionize the understanding of hematologic malignancies. These tools aid in refining diagnoses, identifying new disease subtypes, and predicting treatment responses for better patient outcomes.

Area of Science:

  • Genomics
  • Bioinformatics
  • Hematology

Background:

  • Human cells contain thousands of genes influencing characteristics.
  • Genome sequencing and gene expression measurement have transformed cellular process understanding.
  • Understanding disease mechanisms, especially hematologic malignancies, is crucial.

Purpose of the Study:

  • To review the application of microarrays in analyzing hematologic malignancies.
  • To highlight how these analyses refine diagnosis and identify disease subtypes.
  • To showcase the potential for predicting treatment response and discovering therapeutic targets.

Main Methods:

  • Utilizing high-throughput microarray technology to measure gene expression.
  • Employing bioinformatic and statistical tools for data analysis.

Related Experiment Videos

  • Reviewing case studies of hematologic malignancy analyses.

    • Main Results:

    • Microarray analyses refine diagnosis and identify novel hematologic malignancy subtypes.
    • These studies reveal previously unrecognized relationships between diseases.
    • Identification of genes and pathways linked to pathogenesis enables rational therapy development.

    Conclusions:

    • Microarrays and bioinformatics are powerful tools for hematologic malignancy research.
    • Applications include improved diagnostics, subtype discovery, and treatment prediction.
    • This approach defines targets for developing more effective, rational therapies.